Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors

NCT00661414 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Lpath, Inc.